by Corinne Gangloff
January 31, 2022
Cleveland OH, January 31, 2022 – Mature pharmaceutical markets will continue to drive unit dose packaging sales through 2025, finds a new Freedonia Group analysis:
Nonetheless, countries with developing pharmaceutical packaging markets – led by China and India – will command significantly faster revenue growth over the long term due to expanding pharmaceutical production capabilities, the adoption of stricter pharmaceutical packaging standards, and the evolving need for higher value unit dose containers.
The Freedonia Group projects unit dose pharmaceutical packaging demand to increase 6.4% annually to nearly $57.9 billion in 2025. A heightened focus on patient adherence, infection prevention, and cost accounting in drug delivery will promote growth; unit dose containers contribute favorably to all three. While blister packaging will lead demand value based on solid oral dose applications, prefillable syringes and parenteral vials are expected to generate the fastest growth.
Want to Learn More?
Global Unit Dose Pharmaceutical Packaging, now available from The Freedonia Group, provides historical data (2010, 2015, 2020) and demand forecasts for 2025 and 2030 for unit dose pharmaceutical packaging in millions of US dollars (including inflation) by product type, geographical region, and selected countries. Unit demand for the same years are provided for most product groups.
Among the specific products analyzed are:
Provide the following details to subscribe.